Metraipolis › archive › dc_f602a09e39e6
Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential — Europe PMC PMID:42792248
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42792248
- DOI
- 10.3390/antiox15091209
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T02:28:40.171Z
- SHA-256 of the archived text
09f21f70e3702d475785214d57dc38dae88f2f5e6134bb8bf7d01a46e60417d3- Stable URL of this page
https://metraipolis.com/documento/dc_f602a09e39e6
How to cite
Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential — Europe PMC PMID:42792248 — Europe PMC (en), https://europepmc.org/article/MED/42792248 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f602a09e39e6 (Metraipolis archive dc_f602a09e39e6, sha256 09f21f70e3702d475785214d57dc38dae88f2f5e6134bb8bf7d01a46e60417d3)
BibTeX
@misc{dcf602a09e39e6,
title = {Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential — Europe PMC PMID:42792248},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42792248},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f602a09e39e6; sha256 09f21f70e3702d475785214d57dc38dae88f2f5e6134bb8bf7d01a46e60417d3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42792248. Agents can read the archived copy with the MCP tool read_document.